Pages that link to "Q35770209"
Jump to navigation
Jump to search
The following pages link to Basal-like breast carcinomas: clinical outcome and response to chemotherapy (Q35770209):
Displaying 50 items.
- Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen (Q21092375) (← links)
- Biomarkers in triple negative breast cancer: A review (Q26775094) (← links)
- Triple-negative breast cancer: is there a treatment on the horizon? (Q28077243) (← links)
- The differences in ultrasound and clinicopathological features between basal-like and normal-like subtypes of triple negative breast cancer (Q30417120) (← links)
- Metaplastic breast carcinomas are basal-like tumours (Q33250228) (← links)
- Use of immunohistochemical markers can refine prognosis in triple negative breast cancer (Q33291587) (← links)
- Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients. (Q33506542) (← links)
- microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers (Q33576814) (← links)
- Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer (Q33630849) (← links)
- LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy (Q33740256) (← links)
- Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study (Q33758934) (← links)
- Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma (Q33806378) (← links)
- Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer (Q34088422) (← links)
- Treatment options for patients with triple-negative breast cancer (Q34331406) (← links)
- Topo2α protein expression predicts response to anthracycline combination neo-adjuvant chemotherapy in locally advanced primary breast cancer (Q34433737) (← links)
- Basal-like phenotype in a breast carcinoma case series from Sudan: prevalence and clinical/pathological correlations (Q34512811) (← links)
- Ki67 as a predictor of poor prognosis in patients with triple-negative breast cancer (Q34582473) (← links)
- MYC and Breast Cancer (Q34972381) (← links)
- Pathologic progression of mammary carcinomas in a C3(1)/SV40 T/t-antigen transgenic rat model of human triple-negative and Her2-positive breast cancer (Q35010102) (← links)
- Insulin-like Growth Factor-Dependent Proliferation and Survival of Triple-Negative Breast Cancer Cells: Implications for Therapy (Q35042972) (← links)
- The changing role of pathology in breast cancer diagnosis and treatment (Q35082260) (← links)
- Management Options in Triple-Negative Breast Cancer (Q35155460) (← links)
- Significance of rat mammary tumors for human risk assessment (Q35174533) (← links)
- Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy. (Q35179485) (← links)
- Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes. (Q35549438) (← links)
- Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy (Q35558988) (← links)
- Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib (Q35602598) (← links)
- Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers. (Q35749393) (← links)
- Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival (Q35749421) (← links)
- CD44 Promotes Epithelial Mammary Gland Development and Exhibits Altered Localization during Cancer Progression (Q35755182) (← links)
- Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer (Q35799667) (← links)
- Analysis of Clinical Features and Outcome of 356 Triple-Negative Breast Cancer Patients in China (Q35909551) (← links)
- Basal Breast Cancer: A Complex and Deadly Molecular Subtype (Q35931900) (← links)
- Demystifying basal-like breast carcinomas (Q36172507) (← links)
- Basal-like breast cancer: molecular profiles, clinical features and survival outcomes (Q36325873) (← links)
- A comprehensive morphological study for basal-like breast carcinomas with comparison to nonbasal-like carcinomas (Q36369621) (← links)
- Distinct effects of β1 integrin on cell proliferation and cellular signaling in MDA-MB-231 breast cancer cells (Q36427883) (← links)
- Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up (Q36442340) (← links)
- International Web-based consultation on priorities for translational breast cancer research (Q36465302) (← links)
- Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer (Q36473913) (← links)
- BRCA1 and BRCA2: chemosensitivity, treatment outcomes and prognosis (Q36493340) (← links)
- ER, PR, HER2, Ki-67 and CK5 in Early and Late Relapsing Breast Cancer-Reduced CK5 Expression in Metastases (Q36629859) (← links)
- Identification and characterization of cancer initiating cells from BRCA1 related mammary tumors using markers for normal mammary stem cells (Q36632692) (← links)
- Triple-negative breast cancer: therapeutic options (Q36747692) (← links)
- Breast cancer molecular subtypes and survival in a hospital-based sample in Puerto Rico (Q36977429) (← links)
- SWI/SNF chromatin-remodeling factor Smarcd3/Baf60c controls epithelial-mesenchymal transition by inducing Wnt5a signaling (Q37036337) (← links)
- Clinical and pathologic aspects of basal-like breast cancers (Q37062876) (← links)
- The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy. (Q37081132) (← links)
- EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy (Q37206247) (← links)
- The potential role of nanotechnology in therapeutic approaches for triple negative breast cancer (Q37304764) (← links)